| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.40▼ | 5.40▼ | 5.40▼ | 5.35▼ | 5.32▼ |
| MA10 | 5.52▼ | 5.52▼ | 5.51▼ | 5.36▼ | 5.09▲ |
| MA20 | 5.54▼ | 5.52▼ | 5.52▼ | 5.36▼ | 4.37▲ |
| MA50 | 5.13▲ | 4.91▲ | 4.74▲ | 5.03▲ | 3.64▲ |
| MA100 | 4.42▲ | 4.33▲ | 4.25▲ | 4.35▲ | N/A |
| MA200 | 3.95▲ | 3.79▲ | 3.64▲ | 3.76▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.067▼ | -0.078▼ | -0.085▼ | -0.037▼ | 0.078▲ |
| RSI | 48.417▼ | 51.789▲ | 54.874▲ | 51.526▲ | 70.398▲ |
| STOCH | 24.423 | 31.075 | 29.553 | 34.532 | 63.710 |
| WILL %R | -80.170▼ | -80.170▼ | -80.822▼ | -70.502 | -34.623 |
| CCI | -96.447 | -91.497 | -93.127 | -44.648 | 58.331 |
| ▲ GAP | $EPRX Open Gap Up %2 | Set Alert |
|
Tuesday, August 12, 2025 08:25 AM
On May 5, 2025, the Company announced positive nine-month data from the open-label, dose-escalation Phase 1b/2a RESOLVE trial, which demonstrated sustained positive treatment outcomes in patients with ...
|
|
Wednesday, July 23, 2025 05:01 PM
Fintel reports that on July 24, 2025, Cantor Fitzgerald initiated coverage of Eupraxia Pharmaceuticals (NasdaqCM:EPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 60.92% ...
|
|
Wednesday, July 23, 2025 05:01 PM
Fintel reports that on July 24, 2025, Cantor Fitzgerald initiated coverage of Eupraxia Pharmaceuticals (NasdaqCM:EPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 60.92% ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 5.399 | 5.399 | 5.27 | 5.323 | 2,200 |
| 14/08/25 | 5.56 | 5.56 | 5.27 | 5.28 | 4,174 |
| 13/08/25 | 5.51 | 5.5799 | 5.4069 | 5.45 | 6,631 |
| 12/08/25 | 5.32 | 5.41 | 5.21 | 5.374 | 18,100 |
| 11/08/25 | 5.26 | 5.42 | 5.20 | 5.325 | 15,804 |
| 08/08/25 | 5.2641 | 5.2641 | 5.22 | 5.26 | 5,123 |
| 07/08/25 | 5.4559 | 5.4559 | 5.36 | 5.385 | 3,704 |
| 06/08/25 | 5.37 | 5.45 | 5.37 | 5.42 | 7,700 |
| 05/08/25 | 5.31 | 5.39 | 5.21 | 5.359 | 2,600 |
| 04/08/25 | 5.37 | 5.40 | 5.37 | 5.38 | 1,654 |
|
|
||||
|
|
||||
|
|